Bullfrog AI Holdings Common StockNASDAQ: BFRG

GAITHERSBURG, Md., May 29, 2024 (GLOBE NEWSWIRE) -- BullFrog AI, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable the successful development of pharmaceuticals and biologics, is pleased to invite investors to a webinar on June 12, 2024, at 4:15 p.m. ET.

BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company") announced today that it has made significant progress in its partnership with the Lieber Institute for Brain Development (LIBD), identifying potential drug targets for various neuropsychiatric disorders.

If Bullfrog AI NASDAQ: BFRG is not on your radar yet, it should be. This company is an emerging leader in a subset of AI that will have one of the furthest-reaching impacts on humanity: drug discovery.

Shares of digital technology firm Bullfrog AI (NASDAQ: BFRG ) skyrocketed on Wednesday following an exciting development. Bullfrog, which specializes in leveraging machine learning to usher in a new era of precision medicine, was able to utilize its analytics technology to further the understanding and treatment of psychiatric disorders.

Bullfrog AI Holdings Inc (NASDAQ: BFRG) says early results of its work with the Lieber Institute for Brain Development have been positive. Its shares are up 35% at writing.

GAITHERSBURG, Md., Sept. 14, 2023 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable the successful development of pharmaceuticals and biologics, today announced that its founder and CEO Vin Singh will give a virtual presentation as part of Maxim Group's 2023 Virtual Tech Conference Series, Emerging Growth in AI, scheduled to take place from September 26-27, 2023, and hosted on M-VEST. The presentation will include an overview of the company and its programs with a Q&A for investors in virtual attendance to follow.

BullFrog AI NASDAQ: BFRG surged 44.22% higher yesterday on breaking news and traded almost 55 million shares. The digital pharmaceutical company encompassing artificial intelligence (AI) and machine learning (ML) could be a name to watch.

A major patent achievement has Bullfrog AI (NASDAQ: BFRG ) stock surging more than 30% today. This company is helping bring artificial intelligence (AI) to the development of pharmaceuticals and biologics.

Generative artificial intelligence (AI) is poised to be a tailwind for the MedTech industry over the long term, analysts at UBS believe, with little pointing to AI being a threat in any way. In a note to clients following a conversation between the analysts and an expert in this area, they wrote that both generative AI and AI more broadly will bolster MedTech market growth by increasing procedural volumes as the technology leads to quicker and more accurate diagnosis.